NO20005724L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005724L
NO20005724L NO20005724A NO20005724A NO20005724L NO 20005724 L NO20005724 L NO 20005724L NO 20005724 A NO20005724 A NO 20005724A NO 20005724 A NO20005724 A NO 20005724A NO 20005724 L NO20005724 L NO 20005724L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
NO20005724A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005724D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005724D0 publication Critical patent/NO20005724D0/no
Publication of NO20005724L publication Critical patent/NO20005724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005724A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005724D0 NO20005724D0 (no) 2000-11-13
NO20005724L true NO20005724L (no) 2001-01-09

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
US (1) US6537576B1 (de)
EP (1) EP1082102B1 (de)
JP (1) JP2002514587A (de)
KR (1) KR100592971B1 (de)
CN (1) CN1309553A (de)
AT (1) ATE310500T1 (de)
AU (1) AU736480B2 (de)
CA (1) CA2331527C (de)
DE (2) DE69928524T2 (de)
ES (1) ES2155048T3 (de)
GR (1) GR20010300013T1 (de)
HU (1) HUP0102426A2 (de)
IL (2) IL139576A0 (de)
NO (1) NO20005724L (de)
NZ (1) NZ508073A (de)
PL (1) PL344051A1 (de)
SE (1) SE9801704D0 (de)
TR (1) TR200003589T2 (de)
WO (1) WO1999058108A1 (de)
ZA (1) ZA200006474B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (de) * 2000-02-29 2006-11-29 Zars Inc Verbessertes transdermales medizinpflaster
EP2457560A1 (de) 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topische Zusammensetzungen
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
JP2012504609A (ja) * 2008-10-06 2012-02-23 マイラン・テクノロジーズ，インコーポレイテッド アモルファスロチゴチン経皮システム
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
ES2699257T3 (es) 2013-02-28 2019-02-08 Dermira Inc Sales de glicopirrolato
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
HUP0102426A2 (hu) 2002-03-28
IL139576A0 (en) 2002-02-10
DE1082102T1 (de) 2001-09-06
AU736480B2 (en) 2001-07-26
CN1309553A (zh) 2001-08-22
AU4405099A (en) 1999-11-29
NZ508073A (en) 2002-12-20
DE69928524D1 (de) 2005-12-29
IL139576A (en) 2007-07-04
ES2155048T1 (es) 2001-05-01
KR100592971B1 (ko) 2006-06-23
PL344051A1 (en) 2001-09-24
CA2331527C (en) 2010-04-13
US6537576B1 (en) 2003-03-25
WO1999058108A1 (en) 1999-11-18
ZA200006474B (en) 2001-09-04
CA2331527A1 (en) 1999-11-18
ATE310500T1 (de) 2005-12-15
EP1082102A1 (de) 2001-03-14
TR200003589T2 (tr) 2001-03-21
DE69928524T2 (de) 2006-08-10
EP1082102B1 (de) 2005-11-23
ES2155048T3 (es) 2006-06-16
KR20010052348A (ko) 2001-06-25
NO20005724D0 (no) 2000-11-13
SE9801704D0 (sv) 1998-05-14
JP2002514587A (ja) 2002-05-21
GR20010300013T1 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
BRPI0413432A (pt) método de esterificação de amido
van Iterson et al. A cytochemical localization of reductive sites in a Gram-negative bacterium: tellurite reduction in Proteus vulgaris
Patil et al. Sucrose diacrylate: a unique chemically and biologically degradable crosslinker for polymeric hydrogels
TR200200822T2 (tr) Uçucu bileşiklerin sıvı solüsyon içindeki katı maddelerden çıkarılması süreci
NO20005724D0 (no) Biologisk aktiv sammensetning
BR0109265A (pt) Processo para a obtenção de polihidroxialcanoatos (pha) ou seus copolìmeros e utilização de agentes de redução
Guillory et al. Covalent labeling of the tetrodotoxin receptor in excitable membranes
PT1224455E (pt) Processo de separacao de um composto quimico ou biologico numa mistura de compostos similares por difusao num meio tal como um gel
GB1503402A (en) Orally absorbable sterol glycoside
NO20005725L (no) Biologisk aktiv sammensetning
PT80604B (pt) Processo para a preparacao de esteres dos acidos trimetoxicinamico e isofelurico e de composicoes farmaceuticas contendo os mesmos para o tratamento do adenoma prostatico
DE19634122A1 (de) Neuartige Bäder zur Erzeugung von Mikrostrukturen
TR200000442T2 (tr) Sıvı deterjan bileşimleri ve bunları hazırlamak için işlem.
Hansen A discussion of the paper “scanning electron micrographic studies of ettringite formation,” by PK Mehta★
Sun et al. Should releasing risk of sulfamethoxazole in bound-residual fraction of biochar-soil systems be neglected?
BR9915484A (pt) Processo para o isolamento contìnuo de proteìnas ativas
TW200506531A (en) Photoresist composition for deep uv and process thereof
BR0110365A (pt) Embalagem para dose unitária de detergente e processo de uso
JPS60243165A (ja) 一時的保護被膜及びその製造方法
JPS52105282A (en) Immobilization of enzyme
CA2353529A1 (en) Method for reducing free-radical induced injury
Martin Chemoenzymatic synthesis, characterization and thermodynamic behavior of sugar-containing poly (acrylate) hydrogels
Piccardi et al. Application of a polarographic method for the determination of metals in sewage water).
KR890014025A (ko) 핵용출 화분의 제조방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application